相似文献
1
Blockade of mast cell histamine secretion in response to neurotensin by SR 48692, a nonpeptide antagonist of the neurotensin brain receptor.
Br J Pharmacol. 1995 Apr;114(7):1466-70. doi: 10.1111/j.1476-5381.1995.tb13371.x.
2
Neurotensin stimulation of mast cell secretion is receptor-mediated, pertussis-toxin sensitive and requires activation of phospholipase C.
Immunopharmacology. 1999 Feb;41(2):131-7. doi: 10.1016/s0162-3109(98)00064-2.
3
Inhibition of neurotensin-stimulated mast cell secretion and carboxypeptidase A activity by the peptide inhibitor of carboxypeptidase A and neurotensin-receptor antagonist SR 48692.
Int Arch Allergy Immunol. 1998 Jun;116(2):147-53. doi: 10.1159/000023938.
4
Effect of the neurotensin receptor antagonist SR48692 on rat blood pressure modulation by neurotensin.
Life Sci. 1996;58(8):665-74. doi: 10.1016/s0024-3205(96)80005-1.
5
Inhibitory effects of the neurotensin8-13 analogs Asp13-NT8-13 and Asp12-NT8-13 on mast cell secretion.
Agents Actions. 1993 Jan;38(1-2):1-7. doi: 10.1007/BF02027206.
6
Neurotensin stimulates exocytotic histamine secretion from rat mast cells and elevates plasma histamine levels.
J Physiol. 1982 Feb;323:403-14. doi: 10.1113/jphysiol.1982.sp014080.
7
Interaction of neurotensin with the substance P receptor mediating histamine release from rat mast cells and the flare in human skin.
Br J Pharmacol. 1982 Nov;77(3):531-9. doi: 10.1111/j.1476-5381.1982.tb09328.x.
8
Neurotensin stimulates Cl(-) secretion in human colonic mucosa In vitro: role of adenosine.
Gastroenterology. 2000 Aug;119(2):348-57. doi: 10.1053/gast.2000.9310.
9
Characteristics of beta-endorphin-induced histamine release from rat serosal mast cells. Comparison with neurotensin, dynorphin and compound 48/80.
Naunyn Schmiedebergs Arch Pharmacol. 1988 Nov;338(5):567-72. doi: 10.1007/BF00179331.
引用本文的文献
1
Between two storms, vasoactive peptides or bradykinin underlie severity of COVID-19?
Physiol Rep. 2021 Mar;9(5):e14796. doi: 10.14814/phy2.14796.
2
Neurolysin substrates bradykinin, neurotensin and substance P enhance brain microvascular permeability in a human in vitro model.
J Neuroendocrinol. 2021 Feb;33(2):e12931. doi: 10.1111/jne.12931. Epub 2021 Jan 28.
3
Improvement in blastocyst quality by neurotensin signaling via its receptors in bovine spermatozoa during in vitro fertilization.
J Reprod Dev. 2019 Apr 12;65(2):147-153. doi: 10.1262/jrd.2018-147. Epub 2019 Jan 19.
4
Neurotensin stimulates sortilin and mTOR in human microglia inhibitable by methoxyluteolin, a potential therapeutic target for autism.
Proc Natl Acad Sci U S A. 2016 Nov 8;113(45):E7049-E7058. doi: 10.1073/pnas.1604992113. Epub 2016 Sep 23.
5
Cannabinoid CB1 Receptors Mediate the Gastroprotective Effect of Neurotensin.
Iran J Basic Med Sci. 2012 May;15(3):803-10.
6
HMC-1 human mast cells synthesize neurotensin (NT) precursor, secrete bioactive NT-like peptide(s) and express NT receptor NTS1.
Inflamm Res. 2011 Dec;60(12):1139-51. doi: 10.1007/s00011-011-0378-6. Epub 2011 Sep 17.
7
Advanced glycation end products (AGEs) activate mast cells.
Br J Pharmacol. 2010 Sep;161(2):442-55. doi: 10.1111/j.1476-5381.2010.00905.x.
8
Corticotropin-releasing hormone induces skin vascular permeability through a neurotensin-dependent process.
Proc Natl Acad Sci U S A. 2006 May 16;103(20):7759-64. doi: 10.1073/pnas.0602210103. Epub 2006 May 8.
9
Neurotensin is a proinflammatory neuropeptide in colonic inflammation.
J Clin Invest. 1999 Mar;103(6):843-9. doi: 10.1172/JCI4217.
10
Antagonism by SR 48692 of mechanical responses to neurotensin in rat intestine.
Br J Pharmacol. 1996 Feb;117(3):488-492. doi: 10.1111/j.1476-5381.1996.tb15216.x.
本文引用的文献
1
Biochemical and pharmacological profile of a potent and selective nonpeptide antagonist of the neurotensin receptor.
Proc Natl Acad Sci U S A. 1993 Jan 1;90(1):65-9. doi: 10.1073/pnas.90.1.65.
2
Inhibitory effects of the neurotensin8-13 analogs Asp13-NT8-13 and Asp12-NT8-13 on mast cell secretion.
Agents Actions. 1993 Jan;38(1-2):1-7. doi: 10.1007/BF02027206.
3
Activation of exocytosis by the heterotrimeric G protein Gi3.
Science. 1993 Dec 3;262(5139):1569-72. doi: 10.1126/science.7504324.
4
Parallel secretion of endogenous 5-hydroxytryptamine and histamine from mast cells stimulated by vasoactive peptides and compound 48/80.
Br J Pharmacol. 1984 Feb;81(2):227-9. doi: 10.1111/j.1476-5381.1984.tb10069.x.
5
Structure-activity relationship in the mast cell degranulating capacity of neurotensin fragments.
Neuropharmacology. 1983 Feb;22(2):197-201. doi: 10.1016/0028-3908(83)90009-6.
6
The effects of substance P on histamine and 5-hydroxytryptamine release in the rat.
J Physiol. 1982 Sep;330:393-411. doi: 10.1113/jphysiol.1982.sp014347.
7
Neurotensin stimulates exocytotic histamine secretion from rat mast cells and elevates plasma histamine levels.
J Physiol. 1982 Feb;323:403-14. doi: 10.1113/jphysiol.1982.sp014080.
8
The role of the N-terminal tetrapeptide in the histamine releasing action of substance P.
Neuropharmacology. 1981 Nov;20(11):1025-7. doi: 10.1016/0028-3908(81)90091-5.
9
The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalami.
J Biol Chem. 1973 Oct 10;248(19):6854-61.
10
Calcium-induced extrusion of secretory granules (exocytosis) in mast cells exposed to 48-80 or the ionophores A-23187 and X-537A.
Proc Natl Acad Sci U S A. 1974 Feb;71(2):408-12. doi: 10.1073/pnas.71.2.408.
Zotero 插件